Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Fig. 4

The overall and grouping-related factors of PFS, including overall analysis and grouping analysis.Group1 = Normal weight HCC patients without HBV infection; Group2 = Normal weight HCC patients combined HBV infection; Group3 = Overweight HCC patients without HBV infection; Group4 = Overweight HCC patients combined HBV infection; PFS = progression-free survival; HBV = hepatitis B virus; ECOG = Eastern Cooperative Oncology Group score; BCLC=Barcelona Clinic Liver Cancer; PVTT = portal vein tumor thrombosis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us